Back
Range Cancer Therapeutics ETF Vs. SPDR® S&P Pharmaceuticals ETF Industry Stock Comparison
Sell
49
CNCR
Range Cancer Therapeutics ETF
Last Price:
14.00
Seasonality Move:
2.55%
Buy
61
XPH
SPDR® S&P Pharmaceuticals ETF
Last Price:
45.80
Seasonality Move:
5.85%
Sell
49
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?
- The current Range Cancer Therapeutics ETF [CNCR] share price is $13.79. The Score for CNCR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- CNCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
SPDR® S&P Pharmaceuticals ETF (XPH)
is a Buy
Is SPDR® S&P Pharmaceuticals ETF a Buy, Sell or Hold?
- The current SPDR® S&P Pharmaceuticals ETF [XPH] share price is $45.94. The Score for XPH is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- XPH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CNCR Stock Price Chart
What is Range Cancer Therapeutics ETF's stock price today?
-
The Range Cancer Therapeutics ETF share price today is $13.79
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing selling pressure, which indicates risk of future bearish movement.
XPH Stock Price Chart
What is SPDR® S&P Pharmaceuticals ETF's stock price today?
-
The SPDR® S&P Pharmaceuticals ETF share price today is $45.94
The current trend is moderately bearish and XPH is experiencing slight selling pressure.
CNCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.42 | Sell |
| Relative Strength Index (14 RSI): | 40.74 | Sell |
| Chaikin Money Flow: | -17976 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.81 - 15.43) | Sell |
| Bollinger Bands (100): | (14.1 - 15.46) | Sell |
XPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 48.74 | Sell |
| Chaikin Money Flow: | -25062 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.54 - 47.24) | Sell |
| Bollinger Bands (100): | (42.33 - 46.07) | Buy |
CNCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.55 | Buy |
| 20-day SMA: | 14.53 | Sell |
| 50-day SMA: | 14.82 | Sell |
| 200-day SMA: | 15.04 | Sell |
| 8-day EMA: | 13.77 | Buy |
| 20-day EMA: | 14.27 | Sell |
| 50-day EMA: | 14.62 | Sell |
| 200-day EMA: | 14.55 | Sell |
XPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.71 | Buy |
| 20-day SMA: | 46.44 | Sell |
| 50-day SMA: | 45.61 | Buy |
| 200-day SMA: | 42.87 | Buy |
| 8-day EMA: | 46.08 | Sell |
| 20-day EMA: | 46.18 | Sell |
| 50-day EMA: | 45.58 | Buy |
| 200-day EMA: | 43.31 | Buy |
Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
SPDR® S&P Pharmaceuticals ETF Earnings Growth & XPH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Range Cancer Therapeutics ETF Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
SPDR® S&P Pharmaceuticals ETF Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||